---
schema_version: "secwatch.filing_event.v1"
accession: "0001650664-24-000050"
form_type: "8-K"
ticker: "EDIT"
cik: "0001650664"
company_name: "Editas Medicine, Inc."
filed_at: "2024-05-31T23:59:59+00:00"
generated_at: "2026-06-01T07:10:57.042325+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Editas Medicine stockholders elect Class II directors, approve say-on-pay, ratify auditor

## Summary
- Elected Meeta Chatterjee, Andrew Hirsch, Gilmore O'Neill as Class II directors for term until 2027 annual meeting.
- Advisory say-on-pay approved with 38,609,828 votes for, 2,769,887 against, 205,788 abstentions.
- Ratified Ernst & Young as independent auditor for fiscal 2024 with 57,952,408 votes for, 362,117 against, 1,036,297 abstentions.
- Broker non-votes of 17,765,319 on director election and say-on-pay; none on auditor ratification.

## SEC filing metadata
- accession: 0001650664-24-000050
- form_type: 8-K
- ticker: EDIT
- cik: 0001650664
- company_name: Editas Medicine, Inc.
- filed_at: 2024-05-31T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1650664/000165066424000050/0001650664-24-000050-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1650664/000165066424000050/edit-20240530.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001650664-24-000050
- JSON: https://secwatch.observer/filing/0001650664-24-000050.json
- Plain text: https://secwatch.observer/filing/0001650664-24-000050.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.